MD Angels

MD Angels is a San Francisco-based angel network composed of physician investors, and its identity flows directly from that membership: the network exists to bring clinician judgment and capital to early-stage healthcare companies. Investment activity spans digital health, medical devices, and health IT, areas where physician end-users are central to product validation, distribution, and adoption. The structure gives founders something most generic angel networks cannot, which is a concentrated panel of clinicians prepared to evaluate clinical workflow fit, regulatory positioning, and provider buying behavior. Limited public information is available about specific individual physician members or named partners in this profile, but the network’s clinician-driven posture is its defining feature.

Check sizes are typically under two hundred fifty thousand dollars, deployed at pre-seed and seed stages, often through a syndicate-style mechanism rather than a single fund vehicle. Geographic focus is the United States, with the natural Bay Area density that comes from a San Francisco base. The investment scale positions MD Angels as a complement to other early backers rather than a lead investor on most rounds.

For founders, MD Angels is valuable less for the dollar amount and more for the clinical validation and credibility a physician syndicate brings to a cap table. Expect engagement that probes clinical workflow, end-user adoption, and provider economics, rather than purely financial metrics. Founders building consumer or non-clinical products may find the network less relevant. The right match is an early healthcare company whose product touches clinicians directly and where credible physician backing accelerates both fundraising and pilot conversations.